Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs TAP Block in Sleeve Gastrectomy
NCT06970626Phase 3Recruiting
- Sponsor
- Alexandria University
- Start
- Apr 2025
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of dexmedetomidine in postoperative pain (2 arms), sponsored by Alexandria University. Primary endpoints: Opioid Consumption at 12 hours and Quality of Recovery-40 Questionnaire at 1 day. Started Apr 2025; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06970626.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06970626.